Biblio Discovery — Demo Discovery Service

7 results for "Pascal Finetti"

Showing 1–7 · 0.28 seconds · RSS

  1. Journal Article Full text

    Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer

    Renaud Sabatier; Pascal Finetti; José Adelaide et al.

    PLoS ONE, Vol. 6 No. 11 · 2011 · English · PLOS Scopus

    Introduction: ECRG4/C2ORF40 is a potential tumor suppressor gene (TSG) recently identified in esophageal carcinoma. Its expression, gene copy number and prognostic value have never been explored in breast cancer. Methods: Using DNA microarray and array-based comparative genomic hybridization…

  2. Journal Article Full text

    8q24 Cancer Risk Allele Associated with Major Metastatic Risk in Inflammatory Breast Cancer

    François Bertucci; Arnaud Lagarde; Anthony Ferrari et al.

    PLoS ONE, Vol. 7 No. 5 · 2012 · English · PLOS Scopus

    Background: Association studies have identified low penetrance alleles that participate to the risk of cancer development. The 8q24 chromosomal region contains several such loci involved in various cancers that have been recently studied for their propensity to influence the clinical outcome of…

  3. Journal Article Full text

    Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model

    Martine Humbert; Nathalie Castéran; Sébastien Letard et al.

    PLoS ONE, Vol. 5 No. 3 · 2010 · English · PLOS Scopus

    Background: Tyrosine kinases are attractive targets for pancreatic cancer therapy because several are over-expressed, including PDGFRα/β, FAK, Src and Lyn. A critical role of mast cells in the development of pancreatic cancer has also been reported. Masitinib is a tyrosine kinase inhibitor that…

  4. Journal Article Full text

    Gene Expression Profiling of Solitary Fibrous Tumors

    François Bertucci; Corinne Bouvier-Labit; Pascal Finetti et al.

    PLoS ONE, Vol. 8 No. 5 · 2013 · English · PLOS Scopus

    Background: Solitary fibrous tumors (SFTs) are rare spindle-cell tumors. Their cell-of-origin and molecular basis are poorly known. They raise several clinical problems. Differential diagnosis may be difficult, prognosis is poorly apprehended by histoclinical features, and no effective therapy…

  5. Journal Article Full text

    High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

    Ismahane Bekhouche; Pascal Finetti; José Adelaïde et al.

    PLoS ONE, Vol. 6 No. 2 · 2011 · English · PLOS Scopus

    Background: Inflammatory breast cancer (IBC) is an aggressive form of BC poorly defined at the molecular level. We compared the molecular portraits of 63 IBC and 134 non-IBC (nIBC) clinical samples. Methodology/Findings: Genomic imbalances of 49 IBCs and 124 nIBCs were determined using…

  6. Journal Article Full text

    Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib

    Marine Gilabert; Simon Launay; Christophe Ginestier et al.

    PLoS ONE, Vol. 9 No. 8 · 2014 · English · PLOS Scopus

    Background: Breast cancer stem cells (BCSCs) have been recognized as playing a major role in various aspects of breast cancer biology. To identify specific biomarkers of BCSCs, we have performed comparative proteomics of BCSC-enriched and mature cancer cell populations from the human breast cancer…

  7. Journal Article Full text

    Candidate Luminal B Breast Cancer Genes Identified by Genome, Gene Expression and DNA Methylation Profiling

    Stéphanie Cornen; Arnaud Guille; José Adélaïde et al.

    PLoS ONE, Vol. 9 No. 1 · 2014 · English · PLOS Scopus

    Breast cancers (BCs) of the luminal B subtype are estrogen receptor-positive (ER+), highly proliferative, resistant to standard therapies and have a poor prognosis. To better understand this subtype we compared DNA copy number aberrations (CNAs), DNA promoter methylation, gene expression profiles…